Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 17. March 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9320  Previews Next
   
   Articles 1 - 20 / 186393  
   
Does Tumor Grade Have any Prognostic Significance in Chromophobe Renal Cell Carcinoma: A Clinicopathological Study.
J Cancer Allied Spec
Sadaf S, Mushtaq S, Syed M, Hassan U, Hussain M, Loya A, Hameed M, Sheikh UN.
PMID: 41841143 [PubMed]


A Survey of Oncologists' Perceptions and Opinions Regarding Brain Imaging in Metastatic Renal Cell Carcinoma Within the UK.
Cureus
Crosby BT, Eloebhose E, Saeed MA, Sethi M, Winsor S, Spurr A, Tapia J, Ince W, Frazer R, McGrane J.
PMID: 41841059 [PubMed]


Prevalence and factors associated with lower urinary tract symptoms suggestive of benign prostatic hyperplasia among men aged 50 years and above in Coimbatore district, Tamil Nadu, India: a community-based cross-sectional study.
BMJ Open
Pandi BNS, George S, Olickal JJ, Thankappan KR.
PMID: 41840745 [PubMed - indexed for MEDLINE]


Immune-mediated pathways between red blood cell traits and prostate cancer: a causal relationship network based on Mendelian randomization evaluation.
Aging Male
Yang T, Zhang J, Li J, Yan Q, Li J.
PMID: 41839839 [PubMed - indexed for MEDLINE]


Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis.
BJU Int
Roessler N, Miszczyk M, Gontero P, Dematteis A, Miyajima K, Inoue S, Oberneder K, von Deimling M, Schuettfort VM, Vetterlein MW, Szabados B, Rajwa P, Karakiewicz PI, Teoh JY, Fisch M, Shariat SF.
PMID: 41839747 [PubMed - as supplied by publisher]


ASO Visual Abstract: A Longitudinal Study on Development and Validation of the Prostate Cancer Scale Among the System of Quality of Life Instruments for Cancer Patients (QLICP-PR V2.0) Based on Classical Test Theory and Generalizability Theory.
Ann Surg Oncol
Wei W, Guo F, Zhang T, Chen Y, Li G, Luo J, Wan C.
PMID: 41838357 [PubMed - as supplied by publisher]


The dual role of pyroptosis in prostate cancer: new perspectives from molecular mechanisms to clinical translation.
Mol Biol Rep
Li W.
PMID: 41838288 [PubMed - in process]


Multi-institutional evaluation of prostate specific antigen dynamics after simple prostatectomy.
World J Urol
Livingston AJ, Segal D, Attia S, Dvergsten T, Gahan JC, Morgan TN.
PMID: 41838166 [PubMed - indexed for MEDLINE]


Mendelian Randomization Identified SLC2A9 as a Novel cis-eQTL-Mediated Susceptibility Gene in Suppressing Renal Cancer and Its Related Metabolic Mechanisms.
Mediators Inflamm
Wang Y, Song Y, Ji H, Zhu B, Xie H.
PMID: 41837832 [PubMed - indexed for MEDLINE]


PRAD-Hybrid CNN (PRADHC): A Deep Learning Model for Assisted Diagnosis of Prostate Cancer on MRI.
Curr Med Imaging
Liu J, Hou L, Xu Y, Zhang Y, Zong H.
PMID: 41837512 [PubMed - as supplied by publisher]


Urinary Epithelial Cell Adhesion Molecule (EpCAM) as a Noninvasive Biomarker for Detecting Clinically Significant Prostate Cancer in Men With Equivocal PSA Levels.
Biomed Res Int
Opoku Mensah B, Fondjo LA, Nsiah P, Edwards E.
PMID: 41837413 [PubMed - indexed for MEDLINE]


Editorial Comment on Comparison of Perioperative Chemotherapy Regimens for Muscle-Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials.
Int J Urol
Goto Y.
PMID: 41837348 [PubMed - in process]


Methylation and Expression Analysis of POU4F2, HOXA9, RBM46, and TSGA10 Genes in Bladder Cancer Using Methyl-Sensitive Restriction Enzyme PCR (MSRE-PCR).
Cancer Manag Res
Mahdipour S, Modarressi MH, Noruzinia M.
PMID: 41836594 [PubMed]


Research Status of Androgen Deprivation Therapy Monotherapy and Combination Therapy for Prostate Cancer: A Scoping Review.
Cancer Manag Res
Lu X, Bian X, Wang S, Ye D.
PMID: 41836592 [PubMed]


New-onset renal impairment following radical nephrectomy for renal cell carcinoma: a retrospective cohort study of clinical, intraoperative, and postoperative risk factors.
Ther Adv Urol
Seyam RM, Abduldaem AM, Alfehaid ON, Almaslamani AM, Alghsham FS, Alassaf NM, Alghanam NM, Sayed AG, Elnegali AI, Norris AM, Alzahrani HM.
PMID: 41836458 [PubMed]


Study on the mechanism of 18β-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis.
Front Oncol
Jia S, Zhang L, Li Y, Xu D, Yang Y, Zhou Z, Liu W, Zhao J, Yuan L, Nan Y.
PMID: 41836244 [PubMed]


A systematic characterization of amino acid metabolism-related genes reveals molecular subtypes and a prognostic signature in bladder cancer.
Front Oncol
He J, Liu X, Li S, Xia Z, Tan X, Peng L, Long Q, Wu J.
PMID: 41836241 [PubMed]


Defining recurrent urinary tract infections and quantifying bladder cancer risk in primary care in England: a nationwide case-control study.
Lancet Prim Care
Mahati SG, Wu J, Walter FM, Zhou Y.
PMID: 41836076 [PubMed]


Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies.
Front Pharmacol
Zhang M, Zhang Y, Shen F, Yan M, Cheng P, Teng J, Zou M, Yao W, Wang Z, Li W.
PMID: 41836013 [PubMed]


Dosimetric Impact of Artificial Intelligence (AI)-Based Autocontouring Software, OncoStudio, in High-Risk Prostate Cancer Treatment Planning: A Three-Group Comparative Study on the Slice Ranges of Seminal Vesicles.
Cureus
Kawaguchi M, Hoshina M, Sugahara S, Fujioka K, Takanashi M, Noguchi M, Oosato A, Masuda K, Katada Y, Saito K.
PMID: 41835785 [PubMed]


   
   Articles 1 - 20 / 186393    Page 1 of 9320  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1